Related Experiment Video
Updated: May 10, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Cancer chemoprevention: a rapidly evolving field
1Department of Cancer Studies and Molecular Medicine, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, LE2 7LX, UK. wps1@leicester.ac.uk
Abstract:
Cancer chemoprevention involves the chronic administration of a synthetic, natural or biological agent to reduce or delay the occurrence of malignancy. The potential value of this approach has been demonstrated with trials in breast, prostate and colon cancer. The paradigm for developing new chemopreventive agents has changed markedly in the last decade and now involves extensive preclinical mechanistic evaluation of agents before clinical trials are instituted and a focus on defining biomarkers of activity that can be used as early predictors of efficacy. This review will summarise the current status of the field of chemoprevention and highlight potential new developments.
Insights
Cancer chemoprevention uses agents to delay or reduce cancer. The field now emphasizes preclinical studies and biomarkers to predict treatment effectiveness.
Area of Science:
- Oncology
- Preventive Medicine
Background:
- Cancer chemoprevention is the use of agents to reduce or delay malignancy.
- Previous trials show promise in breast, prostate, and colon cancers.
Purpose of the Study:
- To review the current state of cancer chemoprevention.
- To highlight emerging developments in the field.
Main Methods:
- Review of current literature on cancer chemoprevention.
- Analysis of the evolving paradigm in agent development.
- Focus on preclinical mechanistic evaluation and biomarker identification.
Main Results:
- The field has shifted towards extensive preclinical evaluation.
- Biomarkers are increasingly used to predict efficacy.
- New strategies are emerging for cancer prevention.
Conclusions:
- Cancer chemoprevention is a developing field with evolving methodologies.
- Preclinical research and biomarker development are crucial for future success.
- This review provides an overview of current advancements and future directions.
More Related Videos
05:36Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...